Blu – Pagina 173 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Novembre 15, 2021 Alice Lione

A systematic review and meta‐analysis of interventions to preserve insulin‐secreting β‐cell function in people newly diagnosed with type 1 diabetes: Results from intervention studies aimed at improving glucose control

Narendran P, Tomlinson C, Beese S, et al.
Diabet Med. Pub. online 2 November 2021

Leggi

Novembre 15, 2021 Alice Lione

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis

Nazarzadeh M, Bidel Z, Canoy D, et al.
Lancet. 2021;398(10313):1803-1810.

Leggi

Novembre 15, 2021 Alice Lione

Defining type 2 diabetes remission: KISS goodbye to confusion?

Taheri S
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00290-4

Leggi

Novembre 15, 2021 Alice Lione

Relationships of changes in physical activity and sedentary behavior with changes in physical fitness and cardiometabolic risk profile in individuals with type 2 diabetes: the Italian Diabetes and Exercise Study 2 (IDES_2)

Balducci S, Haxhi J, Sacchetti M, et al.
Diabetes Care. 2021;dc211505.

Leggi

Novembre 8, 2021 Alice Lione

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Del Prato S, Kahn SE, Pavo I, et al.
Lancet. 2021;S0140-6736(21)02188-7

Leggi

Novembre 8, 2021 Alice Lione

Statin Intolerance and Non-Compliance: An Empiric Approach

Grundy SM, Vega GL
Am J Med. 2021;S0002-9343(21)00644-6

Leggi

Novembre 8, 2021 Alice Lione

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Sharma A, Zheng Y, Ezekowitz JA, et al.
Diabetes Care. 2021;dc202806.

Leggi

Novembre 8, 2021 Alice Lione

Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial

Secher AL, Pedersen-Bjergaard U, Svendsen OL, et al.
Diabetologia. 2021;64:2713–2724.

Leggi

Novembre 8, 2021 Alice Lione

The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials

Lin DSH, Lee JK, Hung CS, Chen WJ
Diabetologia. 2021;64:2676–2686.

Leggi

Ottobre 19, 2021 Alice Lione

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

Heerspink HJL, Jongs N, Chertow GM, et al.
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00242-4

Leggi